How Radius Residential Care Limited makes money

Where RAD’s revenue went in FY2025: operating costs, depreciation, interest and tax, and what was left as net profit. Built from the income statement in the filed annual report, and drawn only when the figures reconcile with each other. RAD company profile

How Radius Residential Care Limited makes money — FY2025

Revenue $177.4m · EBITDA $23.5m (13.2% of revenue) · Net profit $7.0m (4.0% of revenue) · Financial year ending March (from the issuer record)

Radius Residential Care Limited (RAD) FY2025: where revenue of $177.4m wentRevenue → EBITDA: $23.5mRevenue → Operating costs (net of other income): $153.9mEBITDA → EBIT: $13.1mEBITDA → Depreciation & amortisation: $10.4mEBIT → Net profit: $7.0mEBIT → Interest: $6.1mOther items (net gain) → Interest: $6.1mOther items (net gain) → Income tax: $3.1mRevenue: $177.4mRevenue$177.4mEBITDA: $23.5mEBITDA$23.5mOperating costs (net of other income): $153.9m (derived)Operating costs (net ofother income)$153.9m · derivedEBIT: $13.1mEBIT$13.1mDepreciation & amortisation: $10.4mDepreciation &amortisation$10.4mOther items (net gain): $9.2m (balancing item)Other items (net gain)$9.2m · balancingNet profit: $7.0mNet profit$7.0mInterest: $12.2mInterest$12.2mIncome tax: $3.1mIncome tax$3.1m

Band widths are proportional to NZD amounts. Dashed outlines mark derived figures; the hatched node is a balancing item (net profit less every line above it).

Radius Residential Care Limited FY2025 figures used in the chart
FY2025AmountStatusNote
Revenue$177.4mReported
Operating costs (net of other income)−$153.9mDerived *Reported operating expenses $41.3m do not reconcile; not used.
EBITDA$23.5mReported
Depreciation & amortisation−$10.4mReported
EBIT$13.1mReported
Interest (net finance costs)−$12.2mReported
Income tax−$3.1mReported
Other items (net gain)+$9.2mBalancing item *Net profit less the lines above; covers fair-value movements, impairments, associates and anything else not itemised.
Net profit$7.0mReported
  • * operating costs: $153.9m = Revenue − EBITDA
Checks run on these figures (6)
  • Passed: Revenue is within the scale of a column stored in thousands.
  • Passed: Revenue in the income statement ($177.4m) vs the summary table ($177.4m): agree within 2%.
  • Passed: EBITDA − D&A = $13.1m vs reported EBIT $13.1m: reconciles.
  • Not met: Reported operating expenses ($41.3m) leave $136.1m, not EBITDA of $23.5m (gap $112.6m); costs derived as revenue minus operating profit instead. No split is shown.
  • Passed: Balancing item $9.2m is 5.2% of revenue (limit 25%).
  • Not met: No operating segments recorded for this year.

Figures extracted automatically from the annual report; check against the report. NZD thousands as stored, shown in millions. Source: annual_report_pdf · method: claude_haiku_pdf · extracted 7 March 2026.

Annual report: Radius Residential Care Limited Annual Report (PDF, NZX)

EBITDA bridge, FY2024 → FY2025

What moved EBITDA between the two years: the change in revenue, less the change in operating costs (revenue less EBITDA, net of other income; not a reported line). The costs are one net figure; no split by type is held, so none is shown.

RAD EBITDA bridge FY2024 to FY2025FY2024 EBITDA: $20.9m$20.9mFY2024 EBITDARevenue change: +$6.2m+$6.2mRevenue changeCost change (derived): −$3.6m−$3.6mCost change (derived)FY2025 EBITDA: $23.5m$23.5mFY2025 EBITDA
RAD EBITDA bridge FY2024 to FY2025: figures
StepFY2024FY2025Effect on EBITDAStatus
FY2024 EBITDA$20.9m$20.9mAs charted
Revenue$171.2m$177.4m+$6.2mReported
Operating costs (net, derived)$150.3m$153.9m−$3.6mDerived: revenue − EBITDA
FY2025 EBITDA$23.5m$23.5mAs charted

$20.9m +$6.2m −$3.6m = $23.5m, which equals FY2025 EBITDA of $23.5m. EBITDA is the figure stored from each statement; companies that headline an adjusted measure (EBITDAF, underlying EBITDA) can report a different number.

What changed from FY2024 to FY2025

MeasureFY2024FY2025ChangeChange %
Revenue$171.2m$177.4m+$6.2m+3.6%
EBITDA$20.9m$23.5m+$2.6m+12.4%
Net profit-$8.5m$7.0m+$15.5mn/m
EBITDA margin12.2%13.2%+1.0 pts—
Net margin-5.0%4.0%+8.9 pts—

Both years passed the same checks. Margins are shares of revenue; their change is in percentage points. n/m = not meaningful (prior-year figure at or below zero). Each year holds the figures from its own annual report; restated comparatives are not applied.

Margins over time

EBITDA, EBIT and net profit as a share of revenue for each year whose figures passed the checks (7 of 9 years from FY2018). The shaded line is the median of 11 other listed Healthcare operating companies, using each one’s same financial year where it passed the checks; the number of companies in each median is in the table. Gaps are years that were not charted.

EBITDA margin
RAD ebitda margin by financial year, with peer median-10%10%30%FY18FY20FY22FY24FY26FY2018: RAD 8.6%; peer median 26.1% (2)FY2019: not charted — not from annual reportFY2020: RAD 8.9%; peer median 9.7% (3)FY2021: RAD 19.1%; peer median 16.8% (3)FY2022: not charted — operating lossFY2023: RAD 9.7%; peer median 15.0% (5)FY2024: RAD 12.2%; peer median 13.4% (7)FY2025: RAD 13.2%; peer median 15.0% (6)FY2026: RAD 13.5%; peer median 10.3% (2)
EBIT margin
RAD ebit margin by financial year, with peer median-10%10%30%FY18FY20FY22FY24FY26FY2018: RAD 5.6%; peer median 27.5% (3)FY2019: not charted — not from annual reportFY2020: RAD 5.6%; peer median 20.1% (5)FY2021: RAD 9.7%; peer median 9.5% (5)FY2022: not charted — operating lossFY2023: RAD 2.9%; peer median 11.5% (5)FY2024: RAD 6.4%; peer median 10.8% (7)FY2025: RAD 7.4%; peer median 13.2% (6)FY2026: RAD 7.0%; peer median 8.9% (2)
Net margin
RAD net margin by financial year, with peer median-10%10%30%FY18FY20FY22FY24FY26FY2018: RAD 3.8%; peer median 19.4% (3)FY2019: not charted — not from annual reportFY2020: RAD 3.9%; peer median 12.0% (5)FY2021: RAD 1.4%; peer median 3.7% (5)FY2022: not charted — operating lossFY2023: RAD -1.4%; peer median 6.2% (5)FY2024: RAD -5.0%; peer median 6.2% (7)FY2025: RAD 4.0%; peer median 14.4% (6)FY2026: RAD 4.7%; peer median 5.1% (2)

RAD   peer median   below the axis: year not charted (reason in the table). All panels share one scale.

RAD margins by year with peer medians
YearEBITDA margin: RAD · peer median (n)EBIT margin: RAD · peer median (n)Net margin: RAD · peer median (n)Note
FY20188.6%26.1% (2)5.6%27.5% (3)3.8%19.4% (3)
FY2019—11.7% (4)—7.2% (5)—3.9% (5)Not charted: not from annual report
FY20208.9%9.7% (3)5.6%20.1% (5)3.9%12.0% (5)
FY202119.1%16.8% (3)9.7%9.5% (5)1.4%3.7% (5)
FY2022—23.7% (5)—19.4% (5)—10.7% (5)Not charted: operating loss
FY20239.7%15.0% (5)2.9%11.5% (5)-1.4%6.2% (5)
FY202412.2%13.4% (7)6.4%10.8% (7)-5.0%6.2% (7)
FY202513.2%15.0% (6)7.4%13.2% (6)4.0%14.4% (6)
FY202613.5%10.3% (2)7.0%8.9% (2)4.7%5.1% (2)

Peer medians use only peer-years that passed the same checks; a median of fewer than two companies is not shown. Years are grouped by financial-year label, and year-end months differ between companies.

Not yet available: where the cash goes (operating cash flow to capex, dividends and debt) and underlying versus reported earnings. The figures they need are not yet validated.

Years not charted

These years are on file but their figures did not pass the checks, so no chart is drawn for them.

  • FY2022: EBIT is $0m. This layout does not draw an operating loss.
  • FY2019: Figures were not read from a filed annual report (source: not recorded).

All companies with a chart

Data sourced from NZX company annual reports (income statements). Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz.

For informational purposes only. Not investment advice.

Get NZX governance insights in your inbox

Weekly digest of board changes, insider trades, and market signals. No spam. Unsubscribe anytime.